市場調査レポート
商品コード
1000448

調剤薬局市場の予測 (2028年まで) - COVID-19の影響と世界市場の分析

Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product ; Therapeutic Area and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 149 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.03円
調剤薬局市場の予測 (2028年まで) - COVID-19の影響と世界市場の分析
出版日: 2021年03月31日
発行: The Insight Partners
ページ情報: 英文 149 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

調剤薬局市場は、2020年の94億4,280万米ドルから、2028年までに149億9,510万米ドルに達し、2021年~2028年のCAGRで6.1%の成長が予測されています。

当レポートでは、世界の調剤薬局市場について調査分析し、市場情勢、市場力学、セグメント別の市場分析、地域別の市場分析、競合情勢、主要企業について、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調剤薬局市場:要点

第3章 調査手法

第4章 世界の調剤薬局市場:市場情勢

  • 概要
  • PEST分析
  • 専門家の見解

第5章 調剤薬局市場:主要な市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 将来動向
  • 影響分析

第6章 調剤薬局市場:世界の分析

  • 世界の調剤薬局市場の収益予測と分析
  • 世界の調剤薬局市場:地域別 - 予測と分析
  • 主要企業の市場ポジショニング

第7章 調剤薬局市場分析:製品別

  • 概要
  • 調剤薬局市場の収益シェア:製品別
  • 経口薬
  • 局所薬
  • 坐薬
  • その他

第8章 調剤薬局市場:治療分野別

  • 概要
  • 調剤薬局市場:治療分野別
  • 鎮痛薬
  • ホルモン補充療法
  • 皮膚科の適応
  • その他

第9章 調剤薬局市場の収益と予測:地域別分析

  • 北米の調剤薬局市場の収益と予測
  • 欧州の調剤薬局市場の収益と予測
  • アジア太平洋地域:調剤薬局市場
  • 中東・アフリカ:調剤薬局市場
  • 中南米の調剤薬局市場の収益と予測

第10章 世界の調剤薬局市場に対するCOVID-19パンデミックの影響

  • 北米:COVID-19パンデミックの影響評価
  • 欧州:COVID-19パンデミックの影響評価
  • アジア太平洋地域:COVID-19パンデミックの影響評価
  • その他の地域:COVID-19パンデミックの影響評価

第11章 調剤薬局市場:業界情勢

  • 概要
  • 市場企業による成長戦略
  • 有機的発展
  • 無機的発展

第12章 企業プロファイル

  • Fagron, Inc.
  • Triangle Compounding Pharmacy
  • B.Braun Melsungen AG
  • PharMEDium Healthcare Holdings, Inc.
  • Fresenius Kabi AG
  • Avella specialty pharmacy
  • Vertisis Custom Pharmacy
  • US Compounding Inc.
  • Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd.
  • Elixir Compounding Pharmacy

第13章 付録

図表

List Of Tables

  • Table 1. A few drugs that are in short supply are listed below:
  • Table 2. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 3. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 4. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 5. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 6. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 7. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 8. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 9. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 10. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 11. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 12. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 13. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 14. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 15. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 16. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 17. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 18. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 19. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 20. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 21. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 22. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 23. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 24. Asia Pacific Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 25. Asia Pacific Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 26. China Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 27. China Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 28. Japan Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 29. Japan Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 30. India Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 31. India Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 32. South Korea Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 33. South Korea Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 34. Australia Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 35. Australia Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 36. Rest of Asia-Pacific: Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 37. Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 38. Middle East and Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
  • Table 39. Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 40. UAE Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
  • Table 41. UAE Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 42. Saudi Arabia Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
  • Table 43. Saudi Arabia Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 44. South Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
  • Table 45. South Africa Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 46. Rest of Middle East and Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 47. Rest of Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • Table 48. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 49. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 50. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 51. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 52. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 53. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 54. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
  • Table 55. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • Table 56. Organic Developments Done By Companies
  • Table 57. Inorganic Developments Done By Companies
  • Table 58. Glossary of Terms, Compounding Pharmacies Market

List Of Figures

  • Figure 1. Compounding Pharmacies Market Segmentation
  • Figure 2. Compounding Pharmacies Segmentation, By Region
  • Figure 3. Global Compounding Pharmacies Market Overview
  • Figure 4. Oral Medications Held Largest Share of Product Segment in Compounding Pharmacies Market
  • Figure 5. North America to Show Remarkable Growth During Forecast Period
  • Figure 6. Compounding Pharmacies Market, by Geography (US$ Million)
  • Figure 7. Global Compounding Pharmacies Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Compounding Pharmacies Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Compounding Pharmacies Market Impact Analysis of Drivers and Restraints
  • Figure 15. Global Compounding Pharmacies Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Global Compounding Pharmacies Market- By Geography Forecast and Analysis - 2020- 2028
  • Figure 17. Market Positioning of Key Players in Global Compounding Pharmacies Market
  • Figure 18. Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)
  • Figure 19. Oral Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Topical Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Suppositories: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)
  • Figure 24. Pain Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Hormone Replacement Therapies: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Dermatological Applications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. North America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
  • Figure 29. North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 31. US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. Canada Compounding Pharmacies Market Revenue And Forecasts to 2028 (US$ Mn)
  • Figure 33. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 34. Europe Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
  • Figure 35. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 37. UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 38. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 39. France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 40. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 41. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 42. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 43. Asia Pacific: Compounding Pharmacies Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 44. Asia Pacific Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Million)
  • Figure 45. China: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 46. Japan: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 47. India: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 48. South Korea: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 49. Australia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 50. Rest of Asia-Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 51. Middle East & Africa: Compounding Pharmacies Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 52. Middle East and Africa Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Millions)
  • Figure 53. UAE: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 54. Saudi Arabia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 55. South Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 56. Rest of Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 57. South and Central America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
  • Figure 58. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 59. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 60. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 61. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 62. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 63. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 64. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 66. Impact Of COVID-19 Pandemic in Rest of The World Market
  • Figure 67. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00005407

The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.

Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth. Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the forecast period. However, product recalls and stringent regulatory requirements hinder the growth of the compounding pharmacies market.

The global compounding pharmacies market is segmented on the basis of product and therapeutic area. Based on product, the market is segmented into oral medications, topical medications, suppositories, and others. The oral medications segment held the largest share of the market in 2020. The growth can be attributed to factors such as it is easy to consume and they come in different forms like solid tablets, capsules, chewable tablets, or lozenges that are easy to be swallowed whole or sucked or as drinkable liquids such as syrups, drops or solutions. Further, the compounding pharmacies market for topical medications segment is expected to grow at the fastest CAGR during 2021-2028. Based on therapeutic area, the compounding pharmacies market is segmented into pain medications, hormone replacement therapies, dermatological applications, and others. The pain medications segment held the largest share of the market in 2020. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the National Health Service (NHS) are among the primary and secondary sources referred to while preparing the report on the compounding pharmacies market.

.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the compounding pharmacies market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global compounding pharmacies market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Compounding Pharmacies Market - By Product
    • 1.3.2 Global Compounding Pharmacies Market - By Therapeutic Area
    • 1.3.3 Global Compounding Pharmacies Market- By Geography

2. Compounding Pharmacies Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Compounding Pharmacies Market- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Compounding Pharmacies Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Drug Shortage Crisis Across the World
    • 5.1.2 Benefits of Compounded Medications
    • 5.1.3 Increasing Adoption of Customized Medicine (Personalized Medicine)
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls and Stringent Regulatory Requirements
  • 5.3 Market Opportunities
    • 5.3.1 Growing Demand for Compounding Pharmacy During COVID-19
  • 5.4 Future Trends
    • 5.4.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products
  • 5.5 Impact Analysis

6. Compounding Pharmacies Market- Global Analysis

  • 6.1 Global Compounding Pharmacies Market Revenue Forecast and Analysis
  • 6.2 Global Compounding Pharmacies Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Compounding Pharmacies Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)
  • 7.3 Oral Medications
    • 7.3.1 Overview
    • 7.3.2 Oral Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Topical Medications
    • 7.4.1 Overview
    • 7.4.2 Topical Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Suppositories
    • 7.5.1 Overview
    • 7.5.2 Suppositories: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

8. Compounding Pharmacies Market - By Therapeutic Area

  • 8.1 Overview
  • 8.2 Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)
  • 8.3 Pain Medications
    • 8.3.1 Overview
    • 8.3.2 Pain Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Hormone Replacement Therapies
    • 8.4.1 Overview
    • 8.4.2 Hormone Replacement Therapies: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Dermatological Applications
    • 8.5.1 Overview
    • 8.5.2 Dermatological Applications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

9. Compounding Pharmacies Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 9.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028
    • 9.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.1.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.1.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
    • 9.1.3 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.1.4 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.1.4.1 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.1.4.2 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.1.5 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.1.5.1 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.1.5.2 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.1.5.3 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.1.6 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.1.6.1 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.1.6.2 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.1.6.3 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • 9.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028
    • 9.2.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.1.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.2.1.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.2.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
    • 9.2.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.3.1 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.3.2 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.2.3.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.2.4 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
        • 9.2.4.1.1 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.4.2 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.2.4.3 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
      • 9.2.4.4 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.2.5 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.5.1 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.2.5.2 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.2.6 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.6.1 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.6.2 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.2.6.3 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.2.7 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.2.8 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.8.1 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.2.8.2 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.2.9 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.2.10 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.2.10.1 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.2.10.2 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
  • 9.3 Asia Pacific: Compounding Pharmacies Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
    • 9.3.3 Asia Pacific: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
    • 9.3.4 Asia Pacific: Compounding Pharmacies Market, by Therapeutic Area - 2019-2028 (USD Million)
    • 9.3.5 Asia Pacific: Compounding Pharmacies Market, by Country, 2020 & 2028 (%)
    • 9.3.6 China: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.6.1 China: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.6.2 China: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
      • 9.3.6.3 China: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.3.7 Japan: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.7.1 Japan: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.7.2 Japan: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
      • 9.3.7.3 Japan: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.3.8 India: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.8.1 India: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.8.2 India: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
      • 9.3.8.3 India: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.3.9 South Korea: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.9.1 South Korea: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.9.2 South Korea: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
      • 9.3.9.3 South Korea: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.3.10 Australia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.10.1 Australia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.10.2 Australia: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
      • 9.3.10.3 Australia: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.3.11 Rest of Asia-Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.11.1 Rest of Asia-Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.3.11.2 Rest of Asia-Pacific: Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
      • 9.3.11.3 Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
  • 9.4 East & Africa: Compounding Pharmacies Market
    • 9.4.1 Overview
    • 9.4.2 Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
    • 9.4.3 Middle East and Africa: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
    • 9.4.4 Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.4.5 Middle East and Africa: Compounding Pharmacies Market, by Country, 2020& 2028 (%)
    • 9.4.6 UAE: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.4.6.1 UAE: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.4.6.2 UAE: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
      • 9.4.6.3 UAE: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.4.7 Saudi Arabia: Compounding Pharmacies Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.1 Saudi Arabia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.4.7.2 Saudi Arabia: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
      • 9.4.7.3 Saudi Arabia: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.4.8 South Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.4.8.1 South Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.4.8.2 South Africa: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
      • 9.4.8.3 South Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
    • 9.4.9 Rest of Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
      • 9.4.9.1 Rest of Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
      • 9.4.9.2 Rest of Middle East and Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
        • 9.4.9.2.1 Rest of Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
  • 9.5 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028
    • 9.5.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.5.1.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.5.1.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.5.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
    • 9.5.3 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.5.4 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.5.4.1 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.5.4.2 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.5.5 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.5.6 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.5.6.1 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.5.6.2 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
    • 9.5.7 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.5.8 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
      • 9.5.8.1 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
      • 9.5.8.2 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

10. Impact Of COVID-19 Pandemic on Global Compounding Pharmacies Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Rest of The World: Impact Assessment of COVID-19 Pandemic

11. Compounding Pharmacies Market- Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Fagron, Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Triangle Compounding Pharmacy
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 B.Braun Melsungen AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 PharMEDium Healthcare Holdings, Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Fresenius Kabi AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Avella specialty pharmacy
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Vertisis Custom Pharmacy
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 US Compounding Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Elixir Compounding Pharmacy
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms